Glutathione-S transferase-II expression in non small cell lung cancer in the assessment of response to chemotherapy

ABSTRACT

To determine the relation of glutathione-S transferase-p [GST-p] expression and cisplatin resistance in non small cell lung cancer [NSCLC]. This study was carried out on 61 patients who were admitted to Chest Diseases Clinic, Ondokuz Mayis University, Samsun, Turkey, from 1997 to 1999. Twenty-seven NSCLC patients out of 61 lung cancer cases whose biopsy specimens were evaluated for GST-p, received multiagent chemotherapy including cisplatin. The correlations between GST-p expression and age, sex, performance score, histology, stage of the disease and response to chemotherapy were investigated. There was a significant correlation between GST-p expression and the histological type of the disease [p<0.05]. However, no significant relation was found with age, sex, performance score or stage of the disease [p>0.05]. Glutathione-S transferase-p staining characteristics of the 27 patients receiving chemotherapy were less than 10% in 3 patients [11.1%], 10-50% in 9 patients [33.3%] and more than 50% in 15 patients [55.5%]. One of the 3 patients [33.3%] with GST-p staining percentage of less than 10%, 3 of 9 patients [33.3%] with staining percentage of 10-50% and 4 out of 15 patients [26.6%] with staining percentage of more than 50% had an objective response to chemotherapy. No significant correlation was found between GST-p expression and response to chemotherapy in the 3 groups [p>0.05]. Glutathione-S transferase-p expression might not always predict the response to combination chemotherapy regimens containing cisplatin. Several other mechanisms may play a role in cisplatin-resistance